Because the reduction of TORC1 activity decreases S6K and eIF-4E activities [38], we tested whether pharmacologic inhibition of this complex with rapamycin would also improve the phenotypes of our Drosophila FRDA model. The gene discussed is RPS6KB1; the disease is Friedreich ataxia.